[go: up one dir, main page]

NO20062616L - Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder - Google Patents

Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder

Info

Publication number
NO20062616L
NO20062616L NO20062616A NO20062616A NO20062616L NO 20062616 L NO20062616 L NO 20062616L NO 20062616 A NO20062616 A NO 20062616A NO 20062616 A NO20062616 A NO 20062616A NO 20062616 L NO20062616 L NO 20062616L
Authority
NO
Norway
Prior art keywords
preparation
treatment methods
new compounds
compositions
matching compositions
Prior art date
Application number
NO20062616A
Other languages
English (en)
Norwegian (no)
Inventor
Orco Philip C Dell
Ann Marie Diederich
Qiaogang Su
Jeffery Lee Wood
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20062616L publication Critical patent/NO20062616L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO20062616A 2003-11-12 2006-06-07 Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder NO20062616L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51916003P 2003-11-12 2003-11-12
US52457403P 2003-11-24 2003-11-24
PCT/US2004/037626 WO2005046608A2 (fr) 2003-11-12 2004-11-12 Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement

Publications (1)

Publication Number Publication Date
NO20062616L true NO20062616L (no) 2006-07-12

Family

ID=34594951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062616A NO20062616L (no) 2003-11-12 2006-06-07 Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder

Country Status (16)

Country Link
US (2) US7754733B2 (fr)
EP (1) EP1689400A4 (fr)
JP (1) JP2007510751A (fr)
KR (1) KR20060122847A (fr)
CN (1) CN1913897B (fr)
AR (1) AR046579A1 (fr)
AU (1) AU2004289318B2 (fr)
BR (1) BRPI0416366A (fr)
CA (1) CA2545876A1 (fr)
IL (1) IL175369A (fr)
IS (1) IS8491A (fr)
MA (1) MA28179A1 (fr)
NO (1) NO20062616L (fr)
RU (1) RU2352572C2 (fr)
TW (1) TWI333492B (fr)
WO (1) WO2005046608A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
EP1943253A1 (fr) * 2005-10-10 2008-07-16 Cipla Limited Nouvelles formes cristallines
US7547785B2 (en) * 2005-12-26 2009-06-16 Dr. Reddy's Laboratories Limited Process for preparing topotecan
US7977483B2 (en) * 2007-04-11 2011-07-12 Scinopharm Taiwan, Ltd. Process for making topotecan
WO2008130534A1 (fr) * 2007-04-19 2008-10-30 Scinopharm Taiwan Ltd. Formes cristallines de chlorhydrate de topotécan et leurs procédés de préparation
US7572803B2 (en) * 2007-10-25 2009-08-11 The Christus Stehlin Foundation For Cancer Research Hydrated crystalline esters of camptothecin
ITMI20072268A1 (it) 2007-12-04 2009-06-05 Antibioticos Spa Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione
US20250295771A1 (en) 2022-05-11 2025-09-25 Celgene Corporation Methods and uses related to t cell therapy and production of same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
AU664830B2 (en) * 1990-09-28 1995-12-07 Smithkline Beecham Corporation Water soluble camptothecin analogues, processes and methods
FR2790261B1 (fr) * 1999-02-26 2004-09-10 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
FR2757514B1 (fr) * 1996-12-20 1999-02-12 Sod Conseils Rech Applic Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
IT1282673B1 (it) * 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
EP1138682A1 (fr) * 1996-12-19 2001-10-04 Dr. Reddy's Research Foundation Nouveaux analogues de noyaux C hydrosolubles de 20(S)-camptothécine
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
CA2461089A1 (fr) * 2001-09-25 2003-04-03 Dr. Reddy's Laboratories Ltd. Sels acceptables d'un point de vue pharmaceutique de 20(s)-camptothecines
US7071202B2 (en) * 2002-02-21 2006-07-04 Supergen, Inc. Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
EP1943253A1 (fr) 2005-10-10 2008-07-16 Cipla Limited Nouvelles formes cristallines
US7547785B2 (en) * 2005-12-26 2009-06-16 Dr. Reddy's Laboratories Limited Process for preparing topotecan
WO2008130534A1 (fr) 2007-04-19 2008-10-30 Scinopharm Taiwan Ltd. Formes cristallines de chlorhydrate de topotécan et leurs procédés de préparation
ITMI20072268A1 (it) * 2007-12-04 2009-06-05 Antibioticos Spa Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione

Also Published As

Publication number Publication date
US7754733B2 (en) 2010-07-13
EP1689400A4 (fr) 2006-12-27
CN1913897B (zh) 2010-08-11
TWI333492B (en) 2010-11-21
IS8491A (is) 2006-05-30
MA28179A1 (fr) 2006-09-01
US20070117832A1 (en) 2007-05-24
KR20060122847A (ko) 2006-11-30
WO2005046608B1 (fr) 2005-12-29
WO2005046608A3 (fr) 2005-11-03
TW200530250A (en) 2005-09-16
IL175369A0 (en) 2008-04-13
IL175369A (en) 2012-03-29
AU2004289318A1 (en) 2005-05-26
RU2352572C2 (ru) 2009-04-20
JP2007510751A (ja) 2007-04-26
US8158645B2 (en) 2012-04-17
BRPI0416366A (pt) 2007-03-13
RU2006120422A (ru) 2007-12-27
CN1913897A (zh) 2007-02-14
US20100210677A1 (en) 2010-08-19
AU2004289318B2 (en) 2010-04-29
AR046579A1 (es) 2005-12-14
CA2545876A1 (fr) 2005-05-26
EP1689400A2 (fr) 2006-08-16
WO2005046608A2 (fr) 2005-05-26

Similar Documents

Publication Publication Date Title
ATE370138T1 (de) Neue imidazopyridine und ihre verwendung
ATE437872T1 (de) Proteinkinaseinhibitoren
ATE365742T1 (de) 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren
WO2001064639A3 (fr) Amides inhibant la pde iv, compositions et procedes de traitement
NO20055421L (no) Kinolinderivater som fosfodiestrase-inhibitorer
NO20051263L (no) Ny anvendelse av benzotiazolderivater
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
WO2000068198A3 (fr) Derives de pyridine heterosubstitues utilises comme inhibiteurs de pde 4
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
IL156827A (en) Derivatives of 2-mercapto- [3,1] thiazolo [4,5 [b- pyridine and pharmaceutical preparations containing them for the treatment of cardiovascular disease
MY133527A (en) Isoquinoline derivatives
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
ECSP055809A (es) Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4
WO2000064874A3 (fr) DERIVES DE PYRIDINE HETEROSUBSTITUES INHIBITEURS DE $i(PDE 4)
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
CA2354606A1 (fr) Derives d'azabicycloalkane et utilisations therapeutiques connexes
NO20062616L (no) Nye forbindelse, samsvarende sammensetninger, fremstilling og/eller behandlingsmetoder
TW200504030A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ATE390923T1 (de) Topoisomerase-giftmittel
WO2003059911A3 (fr) Agents antiviraux 4-oxo-4, 7-dihydrofuro[2,3-b]pyridine-5-carboxamide
GB0319037D0 (en) 7-Azaindole Derivatives
NO20055997L (no) Diarylmetylidenpiperidinderivater og deres anvendelse som opiodreseptoragonister
TW200612970A (en) Biotinylated hexadecasaccharides, preparation and therapeutic use thereof
TW200510313A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application